4 ms·
While I have mixed feelings about The New York Times's coverage of certain topics these days, this is one topic where their reporting has (positively) shaped ev
by drewda 2y ago
While I have mixed feelings about The New York Times's coverage of certain topics these days, this is one topic where their reporting has (positively) shaped events. They had a big investigative piece earlier in the summer about pharmacy benefit managers: https://www.nytimes.com/2024/06/21/business/prescription-drug-costs-pbm.html https://www.nytimes.com/2024/06/21/business/prescription-dru... And that likely led to the recent FTC announcements.
- conductr 2y agoOn this timeline, it seems to me much more likely they caught wind of the FTC’s attention being put on this topic.
- WilTimSon 2y agoNYT is still good at coverage, I'd just argue that the optics of their coverage can be removed from their original, erm, style, at times. (I don't want to say "politics" but we all know I mean politics.) Still, they do excellent work to this day, just with questionable detours.